Recent Finacing
Recent Raise
Calida Therapeutics is a Paris-based preclinical biotechnology company developing monoclonal antibodies that block platelet–myeloid cell crosstalk to prevent and treat thrombo-inflammatory disorders across cardiovascular and autoimmune complications.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor